Search all trials

Find therapies in clinical trials near you – page 24

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 955
countries: 28
conditions: 2 101

3 955 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Acute lymphocytic leukaemia+1

Not yet recruiting

Registered drugNo placebo

A study to evaluate the safety and effectiveness of subcutaneous blinatumomab in adults and adolescents with relapsed, refractory, or minimal residual disease positive B-cell precursor acute lymphoblastic leukemia.

Registered drugNo placebo

France

Participants:0–17 years · 18–64 years · 65+ years
Substances:Blinatumomab

Contact Research Centre

Plasma cell myeloma refractory

Not yet recruiting

Registered drugNo placebo

A Study of Linvoseltamab Alone and Linvoseltamab with Carfilzomib Compared to Standard Treatment in Adults with Relapsed or Refractory Multiple Myeloma

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Aciclovir

Contact Research Centre

Thrombosis prophylaxis

Not yet recruiting

Registered drug

Comparing intermediate and standard doses of enoxaparin to prevent blood clots in patients with severe trauma

Registered drug

France

Participants:18–64 years · 65+ years
Substances:Enoxaparin Sodium

Contact Research Centre

Tracheobronchitis bacterial

Not yet recruiting

Registered drug

A study testing inhaled amikacin compared to placebo in critically ill patients with ventilator-associated tracheobronchitis

Registered drug

France

Participants:18–64 years · 65+ years
Substances:Amikacin

Contact Research Centre

Acute myeloid leukaemia

Not yet recruiting

Registered drugNo placebo

A Study of Ivosidenib and Azacitidine for Patients Over 55 with Acute Myeloid Leukemia and IDH1 Mutation in Complete Remission

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Azacitidine

Contact Research Centre

Systemic candida

Not yet recruiting

Registered drugNo placebo

Study comparing 7-day versus 14-day antifungal treatment for patients with uncomplicated candidemia using fluconazole, anidulafungin, or other medications

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Anidulafungin

Contact Research Centre

Multiple sclerosis+1

Not yet recruiting

Registered drugNo placebo

Testing Antibiotic Treatment Strategies for Patients with Bladder Bacteria Without Symptoms Receiving Botulinum Toxin A Bladder Injections

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Amoxicillin

Contact Research Centre

Non-small cell lung cancer

Not yet recruiting

Registered drug

Study of zipalertinib plus chemotherapy versus placebo plus chemotherapy in patients with stage IB-IIIA non-small cell lung cancer with uncommon EGFR mutations after surgery

Registered drug

France

Participants:18–64 years · 65+ years
Substances:Carboplatin

Contact Research Centre

Cutaneous T-cell lymphoma

Not yet recruiting

Registered drug

Study of brentuximab vedotin for maintenance therapy in patients with cutaneous T-cell lymphoma after stem cell transplant

Registered drug

France

Participants:18–64 years · 65+ years
Substances:Brentuximab Vedotin

Contact Research Centre

Haematological malignancy

Not yet recruiting

Registered drugNo placebo

Study of Reduced Cyclophosphamide Dose After Haploidentical Stem Cell Transplantation in Patients with Blood Cancer

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Cyclophosphamide

Contact Research Centre

Sepsis+1

Not yet recruiting

Registered drugNo placebo

Evaluation of Optimized Ceftazidime Dosing Regimen Versus Standard Treatment for Critical Care Patients with Sepsis

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Ceftazidime

Contact Research Centre

Gastroenteropancreatic neuroendocrine tumour disease+5

Not yet recruiting

Registered drugNo placebo

Study on the Safety and Effectiveness of Domvanalimab and Zimberelimab for Adults with Advanced Rare Cancers Resistant to Standard Treatment

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Domvanalimab

Contact Research Centre

Find therapies in clinical trials near you – page 24

648 trials match your criteria

Acute lymphocytic leukaemia+1

A study to evaluate the safety and effectiveness of subcutaneous blinatumomab in adults and adolescents with relapsed, refractory, or minimal residual disease positive B-cell precursor acute lymphoblastic leukemia.

Plasma cell myeloma refractory

A Study of Linvoseltamab Alone and Linvoseltamab with Carfilzomib Compared to Standard Treatment in Adults with Relapsed or Refractory Multiple Myeloma

Thrombosis prophylaxis

Comparing intermediate and standard doses of enoxaparin to prevent blood clots in patients with severe trauma

Tracheobronchitis bacterial

A study testing inhaled amikacin compared to placebo in critically ill patients with ventilator-associated tracheobronchitis

Acute myeloid leukaemia

A Study of Ivosidenib and Azacitidine for Patients Over 55 with Acute Myeloid Leukemia and IDH1 Mutation in Complete Remission

Systemic candida

Study comparing 7-day versus 14-day antifungal treatment for patients with uncomplicated candidemia using fluconazole, anidulafungin, or other medications

Multiple sclerosis+1

Testing Antibiotic Treatment Strategies for Patients with Bladder Bacteria Without Symptoms Receiving Botulinum Toxin A Bladder Injections

Non-small cell lung cancer

Study of zipalertinib plus chemotherapy versus placebo plus chemotherapy in patients with stage IB-IIIA non-small cell lung cancer with uncommon EGFR mutations after surgery

Cutaneous T-cell lymphoma

Study of brentuximab vedotin for maintenance therapy in patients with cutaneous T-cell lymphoma after stem cell transplant

Haematological malignancy

Study of Reduced Cyclophosphamide Dose After Haploidentical Stem Cell Transplantation in Patients with Blood Cancer

Sepsis+1

Evaluation of Optimized Ceftazidime Dosing Regimen Versus Standard Treatment for Critical Care Patients with Sepsis

Gastroenteropancreatic neuroendocrine tumour disease+5

Study on the Safety and Effectiveness of Domvanalimab and Zimberelimab for Adults with Advanced Rare Cancers Resistant to Standard Treatment

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.